Asthme : qu’attendre des traitements de demain ?
-
Published:2015-04
Issue:3
Volume:55
Page:125-127
-
ISSN:1877-0320
-
Container-title:Revue Française d'Allergologie
-
language:fr
-
Short-container-title:Revue Française d'Allergologie
Author:
Magnan A.,
Chesné J.,
Castan L.,
Bouchaud G.ORCID
Subject
Immunology and Allergy
Reference11 articles.
1. La médecine personnalisée dans l’asthme : c’est maintenant;Blanc;Rev Mal Respir,2013
2. Cluster analysis and clinical asthma phenotypes;Haldar;Am J Respir Crit Care Med,2008
3. National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program;Moore;Am J Respir Crit Care Med,2010
4. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma;Humbert;Allergy,2008
5. A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma;Garcia;Chest,2013